Surgical treatment of patients with tumors of the upper chest wall

Cover Page

Cite item

Full Text

Abstract

Qbiective. To analyze and estimate the oncological and functional results of surgical treatment of patients with tumors of the upper chest wall Materials and methods. During the period from 2005 to 2011 17 patients, with tumors of the upper part of the chest wall with involvement of bone structures, were treated. Primary tumors of the ribs, sternum or clavicle were found in 8 (46,8%) cases, soft tissues tumors of the of the chest wall with invasion of adjacent bony structures in 5 (30%), metastasis of the chest wall was in 4 (23,2%) cases. Isolated involvement of bone structures diagnosed - in 7 (41%) cases, combined - in 10 (59%) cases. Involvement in the neoplastic process of the chest cavity was in 3 (17,4%) cases. Results. Excellent and good orthopedic and functional results were achieved in 14 patients (82%) and satisfactory in 3 (18%) patients. Progressive disease was noted in 4 (23,5%) cases after 3 to 12 months. Median follow-up of patients was 14,7 months. Died from disease progression 4 (23,5%) patients died from disease progression in the period from 10 to 34 months after the surgery. Conclusion. Our results indicate the need for selecting an active surgical approach in this category of patients. The vast majority of the operations in view of the tentative large deficiency of chest wall is not possible to manage without a reconstructive plastic surgery, which allows to restore the function of skeletal completely, and to prevent the development of cardio-respiratory disturbances and thus to achieve good functional and orthopedic outcome.

About the authors

Московский научно-исследовательский онкологический институт им. П.А. Герцена Минздравсоцразвития

Author for correspondence.
Email: oncolog59@yandex.ru
Russian Federation

Московский научно-исследовательский онкологический институт им. П.А. Герцена Минздравсоцразвития

Russian Federation

Московский научно-исследовательский онкологический институт им. П.А. Герцена Минздравсоцразвития

Russian Federation

Московский научно-исследовательский онкологический институт им. П.А. Герцена Минздравсоцразвития

Russian Federation

Московский научно-исследовательский онкологический институт им. П.А. Герцена Минздравсоцразвития

Russian Federation

Московский научно-исследовательский онкологический институт им. П.А. Герцена Минздравсоцразвития

Russian Federation

Московский научно-исследовательский онкологический институт им. П.А. Герцена Минздравсоцразвития

Russian Federation

ФГУ Центральная клиническая больница с поликлиникой УДП РФ

Russian Federation

V. V. Teplakov

Hertcen P.A. Moscow Cancer Research Center

Russian Federation

V. U. Karpenko

Hertcen P.A. Moscow Cancer Research Center

Russian Federation

V. A. Dergavin

Hertcen P.A. Moscow Cancer Research Center

Russian Federation

O. V. Pikin

Hertcen P.A. Moscow Cancer Research Center

Russian Federation

A. V. Buharov

Hertcen P.A. Moscow Cancer Research Center

Russian Federation

S. V. Iepifanova

Hertcen P.A. Moscow Cancer Research Center

Russian Federation

S. G. Dolgova

Hertcen P.A. Moscow Cancer Research Center

Russian Federation

V. E. Kallistov

Federal State Institution «Central Clinical Hospital with policlinic of Russian federation President management department

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 ., ., ., ., ., ., ., ., Teplakov V.V., Karpenko V.U., Dergavin V.A., Pikin O.V., Buharov A.V., Iepifanova S.V., Dolgova S.G., Kallistov V.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.